U.S. FDA Inspections in China

In 2008, foreign manufacturing sites will exceed domestic ones for FDA regulated products for the first time. China had more establishments manufacturing drugs that were offered for entry into the United States than any other country. However, only 11%, or 80 of 714 drug establishments in China, were inspected by the US Food and Drug Administration in fiscal years 2002–2007. From the Heparin debacle to recent infant formula issue, consumers’ concerns are increasing.

Sidley is proud to co-sponsor this Windhover Information, F-D-C Reports and PharmAsia News Webinar.